Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-aminobutyric acid type A receptor subunit rho-1 (GABRR1) is a protein subunit of the GABA(A) receptor that assembles as part of a pentameric, ligand-gated chloride channel mediating the fast inhibitory actions of the major neurotransmitter GABA in the central nervous system. Rho subunit-containing GABA(A) receptors, previously known as GABA(C) receptors, are classically found in the retina, where they contribute to visual signal processing, but are also present in the brain and in non-neural tissues. These receptors are highly selective to GABA and insensitive to classic benzodiazepines, differing in pharmacological profile from other GABA(A) receptor subtypes. GABRR1 variants are associated with several neuropsychiatric conditions, including autism spectrum disorder, epilepsy, bipolar disorder, schizoaffective disorder, and alcohol dependence. Recent research has also implicated GABRR1 in hematopoietic differentiation, especially in the development of megakaryocytes and platelet numbers. Its primary physiological functions include mediating synaptic and extrasynaptic inhibition by permitting chloride influx upon GABA binding, thereby hyperpolarizing neurons and reducing excitability.
Drugs targeting GABRR1 may exert their effects through positive allosteric modulation, antagonism at the GABA binding site, or inhibition or alteration of chloride ion flow (channel blockade).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor subunit rho-1 (GABRR1).